|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: ERT/HRT and breast cancer deathsFrom: Gordon M. Goldman (gmgoldman@sprintmail.com)Tue Dec 17 20:10:27 1996
Philip Suarez, M.D. wrote: > > > BUT how do you tell someone that they're more likely to > > get breast ca but less likely to die from it (and expect them to > > believe you?) > > Stewart: > > Easy. You clearly explain that these findings are consistent with > the fact that those on ERT are more likely to have routine, annual > examination and mammography. Because they are more compliant, they > are more likely to have the "diagnosis" of the disease made, but not > necessarily the poor outcome of death. The diagnosis is made in > compliant patients, typically, in a more curable stage. Agree. Is this not similar to the menopausal woman who can't or won't use Provera with an intact uterus and ERT? As long as she is aware of the risk and is followed closely (she shares that responsibility equally with her physician) she may indeed be at greater risk for endometrial lesion, but usually found early and less likely to be lethal. Gordon -- Life is a sexually transmitted disease and is inevitably fatal. (Borrowed)
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:20:19 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.